Clinical trial
A Single Arm, Two-Stage Phase II Study of Arsenic Trioxide in Previously Treated Small Cell Lung Cancer
NCT01470248 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm, Two-Stage Phase II Study of Arsenic Trioxide in Previously Treated Small Cell Lung Cancer
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- January 31, 2016
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of lung, carcinoma, small cell, lung cancer, pulmonary cancer, pulmonary neoplasms